Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

SecurityAMGN / Amgen Inc.
InstitutionContinuum Advisory, LLC
Latest Disclosed Ownership3,254 shares
Latest Disclosed Value $ 1,144,750
Continuum Advisory, LLC reports 0.12% decrease in ownership of AMGN / Amgen Inc.

On April 22, 2026 - Continuum Advisory, LLC filed a 13F-HR form disclosing ownership of 3,254 shares of Amgen Inc. (US:AMGN) valued at $1,144,920 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 3,258 shares of Amgen Inc.. This represents a change in shares of -0.12% during the quarter. The current value of the position is $1,100,568 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F AMGEN COM 031162100 3,254 -4 -0.12 1,145 7.32 0.1098
2026-02-10 2025-12-31 13F AMGEN INC COM Stock 031162100 3,258 -240 -6.86 1,066 8.00 0.1068
2025-10-20 2025-09-30 13F AMGEN COM 031162100 3,498 -264 -7.02 987 -6.00 0.1044
2025-08-13 2025-06-30 13F AMGEN COM 031162100 3,762 -1,873 -33.24 1,050 -40.17 0.1264
2025-04-23 2025-03-31 13F AMGEN COM 031162100 5,635 481 9.33 1,756 30.68 0.2261
2025-02-18 2024-12-31 13F AMGEN INC COM Stock 031162100 5,154 35 0.68 1,343 -11.29 0.1722
2024-11-15 2024-09-30 13F AMGEN INC COM Stock 031162100 5,119 620 13.78 1,515 7.76 0.1934
2024-07-19 2024-06-30 13F AMGEN INC COM Stock 031162100 4,499 13 0.29 1,406 0.14 0.2026
2024-05-13 2024-03-31 13F AMGEN INC COM Stock 031162100 4,486 -836 -15.71 1,404 -8.48 0.2101
2024-02-14 2023-12-31 13F AMGEN COM 031162100 5,322 987 22.77 1,533 31.70 0.2181
2023-11-13 2023-09-30 13F AMGEN COM 031162100 4,335 1,340 44.74 1,165 75.30 0.1867
2023-12-13 2023-06-30 13F/A-1 AMGEN COM 031162100 2,995 -114 -3.67 665 -11.58 0.1058
2023-08-10 2023-06-30 13F AMGEN COM 031162100 2,995 -114 665 0.1058
2023-12-13 2023-03-31 13F/A-1 AMGEN COM 031162100 3,109 101 3.36 752 -4.94 0.1276
2023-05-12 2023-03-31 13F AMGEN COM 031162100 3,109 101 752 0.1276
2023-12-13 2022-12-31 13F/A-1 AMGEN COM 031162100 3,008 253 9.18 790 27.21 0.1426
2023-02-10 2022-12-31 13F AMGEN COM 031162100 3,008 253 790 0.1426
2023-12-13 2022-09-30 13F/A-1 AMGEN COM 031162100 2,755 -42 -1.50 621 -8.81 0.1095
2022-11-08 2022-09-30 13F AMGEN COM 031162100 2,755 -42 621 0.1095
2023-12-13 2022-06-30 13F/A-1 AMGEN COM 031162100 2,797 205 7.91 681 12.75 0.1239
2022-08-15 2022-06-30 13F AMGEN COM 031162100 2,797 205 681 0.1239
2023-12-13 2022-03-31 13F/A-1 AMGEN COM 031162100 2,592 913 54.38 604 59.79 0.1147
2022-05-17 2022-03-31 13F AMGEN COM 031162100 2,592 913 604 0.1147
2023-12-13 2021-12-31 13F/A-1 AMGEN COM 031162100 1,679 -591 -26.04 378 -21.74 0.0850
2022-02-14 2021-12-31 13F AMGEN COM 031162100 1,679 -591 378 0.0850
2023-12-13 2021-09-30 13F/A-1 AMGEN COM 031162100 2,270 427 23.17 483 7.57 0.1294
2021-11-08 2021-09-30 13F AMGEN COM 031162100 2,270 427 483 0.1294
2023-12-13 2021-06-30 13F/A-1 AMGEN COM 031162100 1,843 1,843 449 0.1396
2021-08-17 2021-06-30 13F AMGEN COM 031162100 1,843 1,843 449 0.1396
2021-05-17 2020-09-30 13F AMGEN COM 031162100 0 -857 -100.00 0 -100.00
2021-05-18 2020-06-30 13F AMGEN COM 031162100 857 857 219 0.1374
2021-05-17 2019-03-31 13F AMGEN COM 031162100 0 -1,394 -100.00 0 -100.00
2021-05-18 2018-12-31 13F AMGEN COM 031162100 1,394 -227 -14.00 271 -19.10 0.1991
2021-05-18 2018-09-30 13F AMGEN COM 031162100 1,621 -897 -35.62 335 -27.96 0.2228
2021-05-18 2018-06-30 13F AMGEN COM 031162100 2,518 -80 -3.08 465 4.97 0.3406
2021-05-18 2018-03-31 13F AMGEN COM 031162100 2,598 -1,387 -34.81 443 -36.08 0.3709
2021-05-18 2017-12-31 13F AMGEN COM 031162100 3,985 111 2.87 693 -4.02 0.5311
2021-05-18 2017-09-30 13F AMGEN COM 031162100 3,874 -66 -1.68 722 6.33 0.6328
2021-05-18 2017-06-30 13F AMGEN COM 031162100 3,940 737 23.01 679 29.09 0.6738
2021-05-18 2017-03-31 13F AMGEN COM 031162100 3,203 3,203 526 0.6314
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.